CClinicalTrials.gg
RecruitingNCT06579326Updated May 6, 2026

Photoacoustic Tomography in Assessment of Lower Extremity Artery Disease

An observational study in Lower Extremity and Photoacoustic, sponsored by Sun Yat-sen University. Recruiting at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-06.

Sponsored by Sun Yat-sen University · Observational

From the registry’s dates

  • Started Nov 2024; still recruiting 1 year 11 months later.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

Lower extremity artery disease (LEAD) is characterized by low awareness rate and high missed diagnosis rate, leading to low treatment rate and high disabling mortality rate. However, none of the current examination methods can comprehensively and thoroughly evaluate the vascular structure and blood oxygen status of the lower extremity at the same time. Photoacoustic imaging can display millimeter-scale microvessels without the need for contrast agents. The investigators developed photoacoustic tomography (PACT) technology, which wass able to provide three-dimensional and high-resolution photoacoustic images of the target area.The investigators plan to recruit LEAD patients in different disease conditions and healthy volunteers to receive the PACT examination on the feet using this imaging system, and to evaluate the potential clinical role of the imaging system in LEAD, and its added value to current imaging methods.

02

Conditions studied

  • Lower Extremity
  • Photoacoustic
03

In context

Lead sponsor

Sun Yat-sen University is the lead sponsor of 1,644 studies on the registry; 602 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The LEAD patients are diagnosed as LEAD by computed tomography angiography or ultrasound.

Inclusion criteria

  1. Inclusion of the case group 1) LEAD patients; 2) Patients voluntarily take part in the study and write informed consent.
  2. Inclusion of the control group 1) Patients without LEAD by ultrasound and clinical diagnosis; 2) Patients voluntarily take part in the study and write informed consent.

Exclusion criteria

Exclusion Criteria:

  1. age \<18 years;
  2. pregnant women, nursing mothers and pregnant women in preparation;
  3. with laser operation contraindication (for example, received a photodynamic therapy in the last month);
  4. with metal implants in lower legs or feet;
  5. with a history of mental illnesses or abuse of drug and alcohol;

7) with blood phobia or pathological hypotension; 8) with cerebral hemorrhage or peripheral vascular bleeding risk, or history of stroke; 9) with wounds in lower legs or feet; 10) unable or uncooperative with the experimenter.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Interventions

  • Diagnostic testPhotoacoustic imaging

    It could provide three-dimensional ultrasound images of vessels in the target area. It could also provides super-resolution and large-depth photoacoustic images. By effectively extracting photoacoustic spectral features and using spectral feature unmixing algorithm, blood oxygen saturation can be calculated.

06

What researchers measure

Primary outcomes

  1. Mean vessel density of foot vasculature measured by photoacoustic imaging

    Vessel density (number of vessels per mm²) in foot vasculature will be quantified using photoacoustic imaging. Results will be reported as mean ± SD.

    Time frame: Baseline

Secondary outcomes

  1. Mean oxygen saturation in pedal vasculature measured by photoacoustic imaging

    Oxygen saturation in pedal vasculature will be quantified by photoacoustic imaging. Results will be reported as mean ± SD. Unit of Measure: %

    Time frame: Baseline

  2. Mean hemoglobin concentration in pedal vasculature measured by photoacoustic imaging

    Description: Hemoglobin concentration in pedal vasculature will be quantified by photoacoustic imaging. Results will be reported as mean ± SD. Unit of Measure: g/dL

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • the Third Affiliated Hospital of Sun Yat-sen University
    Guangzhou, Guangdong 510630, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06579326
Lead sponsor
Sun Yat-sen University
Responsible party
Jia Liu (Principal Investigator, Sun Yat-sen University) — Principal investigator
First posted
Aug 30, 2024
Start date
Nov 1, 2024
Primary completion
Sep 30, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
May 6, 2026

Study contacts

Jia Liu, Doctor
Contact
liujia45@mail.sysu.edu.cn
8602085252010

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion